The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/66/2e/de/662ede70-c619-89ac-12af-65eca2efed05/mza_11590254275384415089.jpg/600x600bb.jpg

FDA Drug Information Updates

ReachMD

20 episodes

7 months ago

Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.

Science

Medicine

RSS

All content for FDA Drug Information Updates is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.

Science

Medicine

The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

FDA Drug Information Updates

8 years ago

The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS. Data in FAERS supports the FDA's post-marketing safety surveillance program for drug products and therapeutic biologic products. Recently, CDER's Office of Surveillance and Epidemiology created and released a tool that makes FAERS data easier to query and retrieve. This new interactive dashboard is designed to expand access of FAERS data to the general public.

Dr. Janet Woodcock, Director of the FDA Center for Drug Evaluation and Research, discusses the advantages of the tool as well as its limitations.